Related references
Note: Only part of the references are listed.Memory T Cell Subsets, Migration Patterns, and Tissue Residence
Scott N. Mueller et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso et al.
BLOOD (2013)
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
Sarah Tettamanti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents
Zahra Sharifzadeh et al.
CANCER LETTERS (2013)
Interleukin 15 Provides Relief to CTLs from Regulatory T Cell-Mediated Inhibition: Implications for Adoptive T Cell-Based Therapies for Lymphoma
Serena K. Perna et al.
CLINICAL CANCER RESEARCH (2013)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek et al.
CLINICAL CANCER RESEARCH (2013)
Interleukin-15 in Gene Therapy of Cancer
Maria C. Ochoa et al.
CURRENT GENE THERAPY (2013)
Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma
P. C. Schuberth et al.
GENE THERAPY (2013)
The immunogenicity of virus-derived 2A sequences in immunocompetent individuals
C. Arber et al.
GENE THERAPY (2013)
Chimeric NKG2D CAR-Expressing T Cell-Mediated Attack of Human Ovarian Cancer Is Enhanced by Histone Deacetylase Inhibition
De-Gang Song et al.
HUMAN GENE THERAPY (2013)
Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials
Xiao-Jun Xu et al.
LEUKEMIA & LYMPHOMA (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
Sid P. Kerkar et al.
MOLECULAR THERAPY (2013)
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Sunitha Kakarla et al.
MOLECULAR THERAPY (2013)
Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
David S. Ritchie et al.
MOLECULAR THERAPY (2013)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genetic instability: tipping the balance
A. Janssen et al.
ONCOGENE (2013)
A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis
Janja Ocvirk et al.
RADIOLOGY AND ONCOLOGY (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy
Perry B. Hackett et al.
TRANSLATIONAL RESEARCH (2013)
Peripheral tissue surveillance and residency by memory T cells
Thomas Gebhardt et al.
TRENDS IN IMMUNOLOGY (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo
Evripidis Lanitis et al.
CANCER IMMUNOLOGY RESEARCH (2013)
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
Marcela V. Maus et al.
CANCER IMMUNOLOGY RESEARCH (2013)
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Zakaria Grada et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
T cell receptor signalling networks: branched, diversified and bounded
Rebecca J. Brownlie et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
Seitaro Terakura et al.
BLOOD (2012)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
De-Gang Song et al.
BLOOD (2012)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till et al.
BLOOD (2012)
Genetically Modified T cells Targeting Interleukin-11 Receptor α-Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
Gangxiong Huang et al.
CANCER RESEARCH (2012)
T cells redirected against HER2 for the adoptive immunotherapy for HER2-positive osteosarcoma
Nabil Ahmed et al.
CANCER RESEARCH (2012)
A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
Katarzyna Urbanska et al.
CANCER RESEARCH (2012)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
Dhanalakshmi Chinnasamy et al.
CLINICAL CANCER RESEARCH (2012)
Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
Koji Tamada et al.
CLINICAL CANCER RESEARCH (2012)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Gene therapy for primary immunodeficiencies: part 1
Marina Cavazzana-Calvo et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
T Cell Affinity Regulates Asymmetric Division, Effector Cell Differentiation, and Tissue Pathology
Carolyn G. King et al.
IMMUNITY (2012)
Cancer-associated fibroblasts as targets for immunotherapy
Sunitha Kakarla et al.
IMMUNOTHERAPY (2012)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
Kevin J. Curran et al.
JOURNAL OF GENE MEDICINE (2012)
Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF
Paul Spear et al.
JOURNAL OF IMMUNOLOGY (2012)
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
Alexia Ghazi et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells
David M. Davies et al.
MOLECULAR MEDICINE (2012)
Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
Adham S. Bear et al.
MOLECULAR THERAPY (2012)
Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
Evripidis Lanitis et al.
MOLECULAR THERAPY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
Manfred Lehner et al.
PLOS ONE (2012)
IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis
Florent Carrette et al.
SEMINARS IN IMMUNOLOGY (2012)
Paths to stemness: building the ultimate antitumour T cell
Luca Gattinoni et al.
NATURE REVIEWS CANCER (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies
Donald R. Shaffer et al.
BLOOD (2011)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Transiently redirected T cells for adoptive transfer
Hilde Almasbak et al.
CYTOTHERAPY (2011)
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
Carlos A. Ramos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
David M. Barrett et al.
HUMAN GENE THERAPY (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Michael Allen et al.
JOURNAL OF PATHOLOGY (2011)
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor
Yozo Nakazawa et al.
MOLECULAR THERAPY (2011)
Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
Ling Zhang et al.
MOLECULAR THERAPY (2011)
Depicting Adoptive Immunotherapy for Prostate Cancer in an Animal Model with Magnetic Resonance Imaging
Reinhard Meier et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Engineered T cells for pancreatic cancer treatment
Usha L. Katari et al.
HPB (2011)
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CDI9-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
Michael C. Jensen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
A High Molecular Weight Melanoma-Associated Antigen-Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas
William R. Burns et al.
CANCER RESEARCH (2010)
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao et al.
CANCER RESEARCH (2010)
Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
Mingli Xu et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
S. Peinert et al.
GENE THERAPY (2010)
Trans-presentation: A novel mechanism regulating IL-15 delivery and responses
Spencer W. Stonier et al.
IMMUNOLOGY LETTERS (2010)
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
Scott Wilkie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
Dhanalakshmi Chinnasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3ζ Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
John S. Bridgeman et al.
JOURNAL OF IMMUNOLOGY (2010)
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V. Hoyos et al.
LEUKEMIA (2010)
Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell-mediated Tumor Eradication
Xiao-Song Zhong et al.
MOLECULAR THERAPY (2010)
T Cells Expressing Constitutively Active Akt Resist Multiple Tumor-associated Inhibitory Mechanisms
Jiali Sun et al.
MOLECULAR THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
Antonio Di Stasi et al.
BLOOD (2009)
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
K. S. Peggs et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
Yangbing Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Szofia S. Bullain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
Nabil Ahmed et al.
MOLECULAR THERAPY (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Noninvasive detection of therapeutic cytolytic T cells with F-18-FHBG PET in a patient with glioma
Shahriar S. Yaghoubi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Detection of human cytomegalovirus in different histological types of gliomas
Michael E. Scheurer et al.
ACTA NEUROPATHOLOGICA (2008)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Brian G. Till et al.
BLOOD (2008)
Efficacy of IL-2-versus IL-15-stimulated CD8 T cells in adoptive immunotherapy
Katja Mueller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
Amorette Barber et al.
EXPERIMENTAL HEMATOLOGY (2008)
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
Claude Sportes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor
Scott Wilkie et al.
JOURNAL OF IMMUNOLOGY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
Duane A. Mitchell et al.
NEURO-ONCOLOGY (2008)
All in the Stroma: Cancer's Cosa Nostra
Jean Marx
SCIENCE (2008)
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
John H. Sampson et al.
SEMINARS IN IMMUNOLOGY (2008)
Memory T cells in cancer immunotherapy:: which CD8+ T-cell population provides the best protection against tumours?
R. Perret et al.
TISSUE ANTIGENS (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Matthias T. Stephan et al.
NATURE MEDICINE (2007)
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes
Concetta Quintarelli et al.
BLOOD (2007)
Epstein!Barr virus-specific cytotoxic T lymphocytes expressing the anti-CD30ξ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease
Barbara Savoldo et al.
BLOOD (2007)
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains
Jinjuan Wang et al.
HUMAN GENE THERAPY (2007)
Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells
Agnieszka Morgenroth et al.
PROSTATE (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
T cell activation by antibody-like immunoreceptors: The position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cells
Andreas A. Hombach et al.
JOURNAL OF IMMUNOLOGY (2007)
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells
Juan Vera et al.
BLOOD (2006)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Immune resistance orchestrated by the tumor microenvironment
Thomas F. Gajewski et al.
IMMUNOLOGICAL REVIEWS (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Rhabdomyosarcoma lysis by T cells expressing a human autoantibody- based chimeric receptor targeting the fetal acetylcholine receptor
S Gattenlohner et al.
CANCER RESEARCH (2006)
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice
JA Westwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine
C Hsu et al.
JOURNAL OF IMMUNOLOGY (2005)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy
T Zhang et al.
BLOOD (2005)
T cell retargeting with MHC class I-restricted antibodies: The CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
RA Willemsen et al.
JOURNAL OF IMMUNOLOGY (2005)
lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
G Dotti et al.
BLOOD (2005)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
Understanding the generation and function of memory T cell subsets
A Lanzavecchia et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens
RD Guest et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1
LJN Cooper et al.
BLOOD (2005)
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells
P Dall et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes
JJ Wang et al.
MOLECULAR THERAPY (2004)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
HJ Wagner et al.
CANCER GENE THERAPY (2004)
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
KS Kahlon et al.
CANCER RESEARCH (2004)
T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity
M Chmielewski et al.
JOURNAL OF IMMUNOLOGY (2004)
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes
JH Pinthus et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes
MWL Teng et al.
HUMAN GENE THERAPY (2004)
Friends or foes - Bipolar effects of the tumour stroma in cancer
MM Mueller et al.
NATURE REVIEWS CANCER (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy
NKV Cheung et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
RJ Brentjens et al.
NATURE MEDICINE (2003)
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
LJN Cooper et al.
BLOOD (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dual-specific T cells combine proliferation and antitumor activity
MH Kershaw et al.
NATURE BIOTECHNOLOGY (2002)
Comparison of the TCR ζ-chain with the FcR γ-chain in chimeric TCR constructs for T cell activation and apoptosis
L Ren-Heidenreich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors
TMJ Niederman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy
C Rossig et al.
BLOOD (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3 zeta-based chimeric immune receptors
DE Gilham et al.
JOURNAL OF IMMUNOTHERAPY (2002)
A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes
RA Willemsen et al.
GENE THERAPY (2001)
Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes
C Rossig et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
IL-15 and IL-2: a matter of life and death for T cells in vivo
XC Li et al.
NATURE MEDICINE (2001)
Redirecting mouse CTL against colon carcinoma: Superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2001)
T cell activation by recombinant FcεRI γ-chain immune receptors:: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition
A Hombach et al.
GENE THERAPY (2000)
Recognition of human colon cancer by T cells transduced with a chimeric receptor gene
T Daly et al.
CANCER GENE THERAPY (2000)
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors
CO Yun et al.
NEOPLASIA (2000)
Ligand-mediated cytolysis of tumor cells: Use of heregulin-zeta chimeras to redirect cytotoxic T lymphocytes
A Muniappan et al.
CANCER GENE THERAPY (2000)